Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about TRAIL: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
Comprehensive information about TRAIL (TNF-Related Apoptosis-Inducing Ligand), a member of the TNF superfamily involved in neuronal apoptosis, neuroinflammation, and neurodegenerative diseases
| Gene Symbol | TNFSF10 |
| Full Name | TNF Superfamily Member 10 (TNF-Related Apoptosis-Inducing Ligand) |
| Chromosome | 3q26.1 |
| Protein Family | TNF superfamily, Type II transmembrane proteins |
| Function | is a member of the tumor necrosis factor (TNF) superfamily that plays complex roles in cell death, immune surveillance, and neuroinflammation. |
| Molecular Weight | 32.5 kDa (monomer), ~97.5 kDa (homotrimer) |
| Amino Acids | 281 aa |
| Pathways | Apoptosis, Immune Response |
| UniProt ID | P50591 |
| Ensembl ID | ENSG00000117586 |
| GeneCards | TNFSF10 |
| Human Protein Atlas | TNFSF10 |
| Protein Length | 281 amino acids |
| Structure | Type II transmembrane protein with extracellular TNF homology domain |
| Cellular Location | Cell surface (membrane-bound) and soluble (cleaved form) |
| Associated Diseases | Als, Cancer, Carcinoma, Ms, Tumor |
| Interactions | TNFRSF1A, FYCO1, DR5, TRAIL, CASP8, TNF |
| KG Connections | 45 knowledge graph edges |
| Databases | GeneCardsNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
TRAIL["<b>TRAIL</b>"]
ALS{"ALS"}
TRAIL -->|"activates"| ALS
Inflammation{"Inflammation"}
TRAIL -->|"activates"| Inflammation
Cancer{"Cancer"}
TRAIL -->|"activates"| Cancer
Tumor{"Tumor"}
TRAIL -->|"inhibits"| Tumor
TRAIL -->|"inhibits"| Cancer
Als{"Als"}
TRAIL -->|"activates"| Als
Ms{"Ms"}
TRAIL -->|"activates"| Ms
TRAIL -->|"activates"| Tumor
CANCER["CANCER"]
TRAIL -->|"inhibits"| CANCER
Immune_Response(["Immune Response"])
TRAIL -->|"inhibits"| Immune_Response
INFLAMMATION["INFLAMMATION"]
TRAIL -->|"activates"| INFLAMMATION
RIPK1["RIPK1"]
TRAIL -->|"activates"| RIPK1
RIPK1 -->|"activates"| TRAIL
JUN["JUN"]
JUN -->|"activates"| TRAIL
TERRA["TERRA"]
TERRA -->|"activates"| TRAIL
AMPK["AMPK"]
AMPK -->|"activates"| TRAIL
INFLAMMATION -->|"activates"| TRAIL
CANCER -->|"activates"| TRAIL
IFNG["IFNG"]
IFNG -->|"inhibits"| TRAIL
GENES["GENES"]
GENES -->|"inhibits"| TRAIL
MHC_I["MHC-I"]
MHC_I -->|"causes"| TRAIL
AND["AND"]
AND -->|"activates"| TRAIL
TRAF6["TRAF6"]
TRAF6 -->|"activates"| TRAIL
JNK["JNK"]
JNK -->|"activates"| TRAIL
style TRAIL fill:#1a3a4a,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| ALS | activates | disease | 0.65 |
| Inflammation | activates | disease | 0.65 |
| Cancer | activates | disease | 0.65 |
| Tumor | inhibits | disease | 0.65 |
| Cancer | inhibits | disease | 0.65 |
| Als | activates | disease | 0.65 |
| Ms | activates | disease | 0.65 |
| Tumor | activates | disease | 0.65 |
| Als | therapeutic_target | disease | 0.65 |
| Cancer | therapeutic_target | disease | 0.65 |
| Lymphoma | therapeutic_target | disease | 0.65 |
| Als | inhibits | disease | 0.65 |
| Lymphoma | inhibits | disease | 0.65 |
| RIPK1 | activates | gene | 0.60 |
| PI3K | activates | gene | 0.60 |
| IFNG | inhibits | gene | 0.60 |
| CASP8 | activates | gene | 0.60 |
| TNF | activates | gene | 0.60 |
| JUN | activates | gene | 0.60 |
| MDM2 | activates | gene | 0.60 |
| DR5 | inhibits | gene | 0.60 |
| Rb | activates | protein | 0.60 |
| Rb | inhibits | protein | 0.60 |
| ER stress | activates | process | 0.60 |
| CANCER | inhibits | gene | 0.60 |
| Immune Response | inhibits | pathway | 0.60 |
| INFLAMMATION | activates | gene | 0.60 |
| CANCER | activates | gene | 0.60 |
| TERRA | activates | gene | 0.60 |
| IFN | activates | gene | 0.60 |
| Akt | activates | pathway | 0.60 |
| Mapk | activates | pathway | 0.60 |
| Apoptosis | activates | pathway | 0.60 |
| Nf-Κb | activates | pathway | 0.60 |
| Pi3K | activates | pathway | 0.60 |
| Glycolysis | activates | pathway | 0.60 |
| P53 | therapeutic_target | gene | 0.60 |
| Apoptosis | therapeutic_target | pathway | 0.60 |
| AMPK | activates | gene | 0.60 |
| AND | activates | gene | 0.60 |
| AND | inhibits | gene | 0.60 |
| MHC-I | causes | gene | 0.60 |
| BCL-2 | therapeutic_target | gene | 0.60 |
| DNA | activates | gene | 0.60 |
| P53 | activates | gene | 0.60 |
| P21 | activates | gene | 0.60 |
| T Cell | inhibits | cell_type | 0.60 |
| MUTANT P53 | inhibits | gene | 0.60 |
| APOPTOSIS | activates | gene | 0.60 |
| BCL-2 | inhibits | gene | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| RIPK1 | activates | gene | 0.60 |
| JUN | activates | gene | 0.60 |
| IFNG | inhibits | gene | 0.60 |
| TRAF6 | activates | gene | 0.60 |
| JNK | activates | gene | 0.60 |
| AKT1 | activates | gene | 0.60 |
| EGFR | activates | gene | 0.60 |
| EGF | activates | gene | 0.60 |
| IRF3 | activates | gene | 0.60 |
| DR5 | therapeutic_target | gene | 0.60 |
| RAB7A | activates | gene | 0.60 |
| TNFSF10 | activates | gene | 0.60 |
| TNFRSF1A | activates | gene | 0.60 |
| FYCO1 | activates | gene | 0.60 |
| DR5 | activates | gene | 0.60 |
| RIPK1 | phosphorylates | entity | 0.60 |
| IFNG | associated_with | entity | 0.60 |
| IFNG | activates | entity | 0.60 |
| IFNG | causes | gene | 0.60 |
| DR5 | inhibits | gene | 0.60 |
| PD1 | causes | gene | 0.60 |
| PD1 | activates | gene | 0.60 |
| FADD | associated_with | gene | 0.60 |
| TNF | associated_with | gene | 0.60 |
| TERRA | activates | gene | 0.60 |
| AMPK | activates | gene | 0.60 |
| INFLAMMATION | activates | gene | 0.60 |
| CANCER | activates | gene | 0.60 |
| GENES | inhibits | gene | 0.60 |
| MHC-I | causes | gene | 0.60 |
| APOPTOSIS | activates | gene | 0.60 |
| RAS | activates | gene | 0.60 |
| NF-ΚB | activates | gene | 0.60 |
| APOPTOSIS | therapeutic_target | gene | 0.60 |
| AND | therapeutic_target | gene | 0.60 |
| BCL-2 | therapeutic_target | gene | 0.60 |
| CANCER | therapeutic_target | gene | 0.60 |
| AND | activates | gene | 0.60 |
| AMPK | phosphorylates | entity | 0.60 |
| P53 | therapeutic_target | gene | 0.60 |
| DR5 | co_expressed_with | gene | 0.50 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||